Treatment of tumor cells with supernatant from wild-type CLPTM1L overexpressing cells did not cause a detectable increase in phosphorylation of Akt compared to treatment with supernatants from ΔLoop CLPTM1L overexpressing cells. The gene discussed is AKT1; the disease is neoplasm.